The VC neurons are a class of six post-embryonic motor neurons with synapses on the vulva muscles, other body muscles, and a few other motor neurons (White et al.). In late L4, all six VCs develop FMRFamide-like immunoreactivity (Schinkmann and Li) and some are induced to branch by the vulva (Li and Chalfie). We have used specific antibodies to determine that some of the VCs probably use acetylcholine and a monoamine as well as a FMRFamide-like peptide as neurotransmitters. The antibodies we used were generated against synaptic proteins, so they only weakly label cell bodies (whose position aids greatly in cell identification). Therefore, we used
unc-104 mutants (in which synaptic proteins are mislocalized in somas) as well as over-expressing transgenic lines (in which 'excess' protein is found in somas) to identify neurons. In adults, all of the VCs are usually labeled with antibodies to two cholinergic markers, the acetylcholine synthetic enzyme choline acetyltransferase (ChAT, encoded by
cha-1 ) and the vesicular acetylcholine transporter (VAChT, encoded by
unc-17 ). VC4 and VC5, but not the other VCs, are also labeled with antibodies to a monoaminergic marker, the vesicular monoamine transporter (VMAT, encoded by
cat-1 ). Antibodies to ChAT, VAChT, and VMAT label the VC motor neurons in slightly different patterns spatially and temporally. When the VCs are born in late L1, they do not exhibit detectable cholinergic or aminergic immunoreactivity. This is consistent with the expression pattern of other post-embryonic cholinergic neurons. During larval development, the intensity of cholinergic immunoreactivity increases fairly uniformly in most post-embryonic ventral nerve cord cholinergic neurons. However, some of the VCs continue to lack detectable immunoreactivity or express very low and variable levels. As the vulva develops, ChAT and VMAT immunoreactivity greatly increase in VC4 and VC5 and increase slightly in some of the other VCs. This is followed by expression of VMAT in VC4 and VC5 (but not in the other VCs). We are studying the temporal and spatial patterns of these and other late VC markers to try and understand their regulation and relevance. This work was supported by grants from OCAST and NIH.